Nucleai, Mayo Clinic partner on digital pathology
Nucleai and Mayo Clinic BioPharma Diagnostics on Monday announced a strategic collaboration involving digital pathology solutions, technologies, and services to support drug development and clinical practice. Read More
Adaptive Biotechnologies, Genentech announce FDA acceptance of investigational new drug application
Adaptive Biotechnologies on Tuesday announced that the U.S. Food and Drug Administration (FDA) has accepted an investigational new drug (IND) application submitted by its collaborator, Genentech, for a neoantigen-directed T-cell receptor (TCR)-based T-cell therapy. Read More
Roche launches Institute of Human Biology for human model systems to advance research and drug development
Roche on Thursday announced the launch of the Institute of Human Biology (IHB), focused on advancing medical research through human model systems such as organoids. Using human model systems, the IHB aims to accelerate drug discovery and development through understanding how diseases develop and organs function. Read More
SomaLogic CEO steps down; Q4 revenue declines 18%
Aptamer-based proteomics firm SomaLogic said after the close of the market on Tuesday that its fourth-quarter revenue declined 18% year over year, primarily due to the recognition of $1.9 million of licensing revenue in the fourth quarter of 2021. Read More
Swiss spatial biology firm Lunaphore raises 40 million Swiss francs
Lausanne, Switzerland-based Lunaphore said Thursday it has closed 40 million Swiss francs (CHF) ($43.5 million) in a Series D1 financing. Read More
Sophia Genetics partnering with Agilent Technologies to offer cancer analysis solution
Healthcare software firm Sophia Genetics said on Tuesday that it is partnering with Agilent Technologies to offer a comprehensive solution for cancer analysis. Read More
PerkinElmer completes divestiture of Applied, Food, and Enterprise Services businesses to New Mountain Capital
PerkinElmer on Monday announced that it has completed its previously announced divestiture of its Applied, Food, and Enterprise Services businesses to New Mountain Capital, a growth-oriented investment firm. Read More
Theratechnologies data suggests tesamorelin may improve metabolic profiles in people with HIV
Biopharma firm Theratechnologies recently presented data suggesting that tesamorelin, a growth hormone-releasing hormone analogue, may improve metabolic profiles in people with by reducing excess visceral abdominal fat (EVAF). Read More
Viz.ai platform to be used in patient enrollment for pulmonary embolism trial
Viz.ai announced on Saturday that its AI-enabled, cloud-based Viz Recruit platform will be used to expedite patient enrollment in the Pulmonary Embolism -- Thrombus Removal with Catheter-Directed Thrombolysis (PE-TRACT) clinical trial. Read More
Quanterix expands laboratory-developed-test menu with launch of neurofilament light chain test
Quanterix on Monday announced the validation of a laboratory developed test (LDT) to quantitatively measure neurofilament light chain (NfL) in serum as an aid in the evaluation of individuals for possible neurodegenerative conditions or other causes of neuronal or central nervous system damage. Read More
Member Rewards
Earn points for contributing to market research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Research Topics
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Connect
